Brief: Humanigen Submits Application To FDA For Emergency Use Authorization For Lenzilumab In COVID-19
May 28 (Reuters) - Humanigen Inc HGEN.O :
* HUMANIGEN SUBMITS APPLICATION TO FDA FOR EMERGENCY USE
AUTHORIZATION FOR LENZILUMAB IN COVID-19
Source text for Eikon: ID:nBwb8NqCsa
Further company coverage: HGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Humanigen
See all newsPress Digest: Wall Street Journal - Jan 5
Covid: 19 treatment developer Humanigen files for Chapter 11 bankruptcy
Brief: Humanigen Files For Voluntary Chapter 11 Bankruptcy - Court Filing
Brief: Covid-19 Treatment Developer Humanigen Files For Bankruptcy - WSJ
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners